Anna Novials

Summary

Country: Spain

Publications

  1. ncbi Islet amyloid polypeptide gene promoter polymorphisms are not associated with Type 2 diabetes or with the severity of islet amyloidosis
    Christopher Esapa
    Diabetes Research Laboratories, Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Oxford, OX3 7LJ, UK
    Biochim Biophys Acta 1740:74-8. 2005
  2. ncbi The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control
    Ana Chico
    Institute of Diabetology, Fundació Sardà Farriol, Barcelona, Spain
    Diabetes Care 26:1153-7. 2003
  3. ncbi Amylin and hypertension: association of an amylin -G132A gene mutation and hypertension in humans and amylin-induced endothelium dysfunction in rats
    Anna Novials
    Institute of Diabetes, Sardà Farriol Foundation, Passeig Bonanova 69, 6th Floor, 08017 Barcelona, Spain
    J Clin Endocrinol Metab 92:1446-50. 2007
  4. ncbi Silent myocardial ischemia is associated with autonomic neuropathy and other cardiovascular risk factors in type 1 and type 2 diabetic subjects, especially in those with microalbuminuria
    Ana Chico
    Institute of Diabetes, Fundación Sardà Farriol, Barcelona, Spain
    Endocrine 27:213-7. 2005
  5. ncbi Impairment of the ubiquitin-proteasome pathway is a downstream endoplasmic reticulum stress response induced by extracellular human islet amyloid polypeptide and contributes to pancreatic beta-cell apoptosis
    Silvia Casas
    Endocrinology and Diabetes Unit, Laboratory of Experimental Diabetes, Institut d Investigacions Biomediques August Pi i Sunyer, Hospital Clinic and University of Barcelona, Barcelona, Spain
    Diabetes 56:2284-94. 2007
  6. ncbi The Korle-Bu Hb variant in Caucasian women with type 1 diabetes: a pitfall in the assessment of diabetes control
    Ana Chico
    Diabetes Care 27:2280-1. 2004
  7. ncbi The HFE gene is associated to an earlier age of onset and to the presence of diabetic nephropathy in diabetes mellitus type 2
    Rafael Oliva
    Grup de Genètica Molecular, Hospital Clinic, Faculty of Medicine, University of Barcelona, Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, Barcelona, Spain
    Endocrine 24:111-4. 2004

Collaborators

  • R Oliva
  • Ana Chico
  • Silvia Casas
  • Ramon Gomis
  • Christopher Esapa
  • Sakari Knuutila
  • Fiona M Gribble
  • Jordi Altirriba
  • Jonathan C Levy
  • Marku Laakso
  • Catherine M McNamara
  • Jennifer H Moffitt
  • Antoni Tomás
  • Anne Clark
  • Anna Padrós
  • Pablo Vidal-Ríos
  • Montserrat Subirà

Detail Information

Publications7

  1. ncbi Islet amyloid polypeptide gene promoter polymorphisms are not associated with Type 2 diabetes or with the severity of islet amyloidosis
    Christopher Esapa
    Diabetes Research Laboratories, Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Oxford, OX3 7LJ, UK
    Biochim Biophys Acta 1740:74-8. 2005
    ..The IAPP-132G/A promoter polymorphism is not associated with T2DM, a requirement for insulin therapy or with the degree of islet amyloidosis in cohorts from the UK or Finland...
  2. ncbi The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control
    Ana Chico
    Institute of Diabetology, Fundació Sardà Farriol, Barcelona, Spain
    Diabetes Care 26:1153-7. 2003
    ....
  3. ncbi Amylin and hypertension: association of an amylin -G132A gene mutation and hypertension in humans and amylin-induced endothelium dysfunction in rats
    Anna Novials
    Institute of Diabetes, Sardà Farriol Foundation, Passeig Bonanova 69, 6th Floor, 08017 Barcelona, Spain
    J Clin Endocrinol Metab 92:1446-50. 2007
    ..The -132 G/A mutation located within an activator domain of the amylin gene's promoter was first identified in a small cohort of Spanish patients with type 2 diabetes...
  4. ncbi Silent myocardial ischemia is associated with autonomic neuropathy and other cardiovascular risk factors in type 1 and type 2 diabetic subjects, especially in those with microalbuminuria
    Ana Chico
    Institute of Diabetes, Fundación Sardà Farriol, Barcelona, Spain
    Endocrine 27:213-7. 2005
    ..05). We conclude that diabetic patients aged over 60 with autonomic neuropathy and other cardiovascular risk factors should be screened for the presence of SMI especially if they have increased microalbuminuria...
  5. ncbi Impairment of the ubiquitin-proteasome pathway is a downstream endoplasmic reticulum stress response induced by extracellular human islet amyloid polypeptide and contributes to pancreatic beta-cell apoptosis
    Silvia Casas
    Endocrinology and Diabetes Unit, Laboratory of Experimental Diabetes, Institut d Investigacions Biomediques August Pi i Sunyer, Hospital Clinic and University of Barcelona, Barcelona, Spain
    Diabetes 56:2284-94. 2007
    ..It is known that extracellular hIAPP oligomers are toxic to pancreatic beta-cells and associated with apoptosis. We therefore investigated the molecular mechanism by which extracellular hIAPP mediates pancreatic beta-cell apoptosis...
  6. ncbi The Korle-Bu Hb variant in Caucasian women with type 1 diabetes: a pitfall in the assessment of diabetes control
    Ana Chico
    Diabetes Care 27:2280-1. 2004
  7. ncbi The HFE gene is associated to an earlier age of onset and to the presence of diabetic nephropathy in diabetes mellitus type 2
    Rafael Oliva
    Grup de Genètica Molecular, Hospital Clinic, Faculty of Medicine, University of Barcelona, Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, Barcelona, Spain
    Endocrine 24:111-4. 2004
    ..To our knowledge our study is the first one to report an earlier age of onset in type 2 diabetic patients carrying HFE mutations...